Literature DB >> 9815079

Ultrarapid delayed rectifier current inactivation in human atrial myocytes: properties and consequences.

J Feng1, D Xu, Z Wang, S Nattel.   

Abstract

The ultrarapid delayed rectifier current (IK,ur) plays a significant role in human atrial repolarization and is generally believed to show little rate dependence because of slow and partial inactivation. This study was designed to evaluate in detail the properties and consequences of IK,ur inactivation in isolated human atrial myocytes. IK,ur inactivated with a biexponential time course and a half-inactivation voltage of -7.5 +/- 0.6 mV (mean +/- SE), with complete inactivation during 50-s pulses to voltages positive to +10 mV (37 degreesC). Recovery from inactivation proceeded slowly, with time constants of 0.42 +/- 0.06 and 7.9 +/- 0.9 s at -80 mV (37 degreesC). Substantial frequency dependence was observed at 37 degreesC over a clinically relevant range of frequencies. Inactivation was faster and occurred at more positive voltages at 37 degreesC compared with room temperature. The voltage and time dependencies of Kv1.5 inactivation were studied in Xenopus oocytes to avoid overlapping currents and strongly resembled those of IK,ur in native myocytes. We conclude that, while IK,ur inactivation is slow, it is extensive, and slow recovery from inactivation confers important frequency dependence with significant consequences for understanding the role of IK,ur in human atrial repolarization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815079     DOI: 10.1152/ajpheart.1998.275.5.H1717

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  26 in total

1.  The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes.

Authors:  P Schaffer; B Pelzmann; E Bernhart; P Lang; H Mächler; B Rigler; B Koidl
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

3.  Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs.

Authors:  Sandeep V Pandit; Sharon Zlochiver; David Filgueiras-Rama; Sergey Mironov; Masatoshi Yamazaki; Steven R Ennis; Sami F Noujaim; Antony J Workman; Omer Berenfeld; Jerome Kalifa; José Jalife
Journal:  Cardiovasc Res       Date:  2010-11-13       Impact factor: 10.787

Review 4.  New developments in atrial antiarrhythmic drug therapy.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 5.  Modification of K+ channel-drug interactions by ancillary subunits.

Authors:  Glenna C L Bett; Randall L Rasmusson
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

6.  Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5.

Authors:  Isabelle Plante; Dominique Fournier; Guylaine Ricard; Benoît Drolet; Gilles O'Hara; Jean Champagne; Patrick Mathieu; Richard Baillot; Pascal Daleau
Journal:  Pflugers Arch       Date:  2006-01-13       Impact factor: 3.657

7.  K+ current changes account for the rate dependence of the action potential in the human atrial myocyte.

Authors:  Mary M Maleckar; Joseph L Greenstein; Wayne R Giles; Natalia A Trayanova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

8.  Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium.

Authors:  L Yue; Z Wang; H Rindt; S Nattel
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

Review 9.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

10.  Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium.

Authors:  Mary M Maleckar; Joseph L Greenstein; Natalia A Trayanova; Wayne R Giles
Journal:  Prog Biophys Mol Biol       Date:  2009-01-30       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.